Taking these clinical data together, adjuvant IL-7 exhibited great potential in immunological reconstitution, including prompting expansion of T cells, inducing cytokine production, maintaining memory response, and arousing resistance to immune suppression, when combined with cancer vaccines to struggle against tumors. This evidence concerns the gene IL7 and cancer.